Surgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) have received a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $34.75.

A number of brokerages have recently weighed in on SGRY. Royal Bank of Canada reiterated an “outperform” rating and issued a $35.00 target price on shares of Surgery Partners in a report on Tuesday, March 25th. Benchmark reiterated a “buy” rating and issued a $35.00 target price on shares of Surgery Partners in a research report on Monday. Finally, Macquarie lowered their price target on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a report on Tuesday, March 11th.

Insider Activity at Surgery Partners

In other Surgery Partners news, CFO David T. Doherty sold 13,641 shares of the business’s stock in a transaction on Friday, February 7th. The shares were sold at an average price of $25.61, for a total transaction of $349,346.01. Following the completion of the transaction, the chief financial officer now owns 108,862 shares of the company’s stock, valued at $2,787,955.82. The trade was a 11.14 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Harrison R. Bane sold 56,315 shares of the company’s stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the sale, the insider now owns 107,037 shares of the company’s stock, valued at $2,744,428.68. This trade represents a 34.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 106,622 shares of company stock valued at $2,717,860. Insiders own 2.30% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. KBC Group NV raised its stake in Surgery Partners by 66.1% during the 4th quarter. KBC Group NV now owns 3,962 shares of the company’s stock valued at $84,000 after purchasing an additional 1,577 shares during the last quarter. State of Wyoming grew its stake in shares of Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company’s stock valued at $85,000 after purchasing an additional 1,943 shares during the period. Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Surgery Partners by 12.1% in the 4th quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company’s stock worth $91,000 after buying an additional 465 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Surgery Partners by 7,902.7% during the 1st quarter. GAMMA Investing LLC now owns 8,883 shares of the company’s stock worth $211,000 after buying an additional 8,772 shares during the period. Finally, MeadowBrook Investment Advisors LLC boosted its stake in Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after buying an additional 1,460 shares in the last quarter.

Surgery Partners Stock Up 1.5 %

SGRY stock opened at $20.51 on Friday. The company’s 50 day simple moving average is $23.33 and its 200-day simple moving average is $24.23. Surgery Partners has a 52-week low of $19.50 and a 52-week high of $33.97. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The firm has a market capitalization of $2.62 billion, a P/E ratio of -42.73, a P/E/G ratio of 19.21 and a beta of 2.40.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company had revenue of $864.40 million during the quarter, compared to analyst estimates of $828.09 million. As a group, equities research analysts anticipate that Surgery Partners will post 0.67 EPS for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.